A carregar...
Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker
Immune checkpoint blockade (ICB) has achieved unprecedented breakthroughs in various cancers, including gastric cancer (GC) with high immune activity (MSI-H or TMB-H), yet clinical benefits from ICB were moderate. Here we aimed to identify the most appropriate drugs which can improve outcomes in GC....
Na minha lista:
| Publicado no: | Aging (Albany NY) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7803585/ https://ncbi.nlm.nih.gov/pubmed/33221769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104084 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|